Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4793468
Max Phase: Preclinical
Molecular Formula: C34H32N4O7S2
Molecular Weight: 672.78
Molecule Type: Unknown
Associated Items:
ID: ALA4793468
Max Phase: Preclinical
Molecular Formula: C34H32N4O7S2
Molecular Weight: 672.78
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@@]1(OC(=O)[C@H](CCSC)NC(=S)NC(=O)c2ccc(OC)cc2)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1
Standard InChI: InChI=1S/C34H32N4O7S2/c1-4-34(45-31(41)26(13-14-47-3)36-33(46)37-29(39)19-9-11-22(43-2)12-10-19)24-16-27-28-21(15-20-7-5-6-8-25(20)35-28)17-38(27)30(40)23(24)18-44-32(34)42/h5-12,15-16,26H,4,13-14,17-18H2,1-3H3,(H2,36,37,39,46)/t26-,34-/m0/s1
Standard InChI Key: BCHCEMIHEUIXII-JKFCTSDTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 672.78 | Molecular Weight (Monoisotopic): 672.1712 | AlogP: 4.07 | #Rotatable Bonds: 9 |
Polar Surface Area: 137.85 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.28 | CX Basic pKa: 3.07 | CX LogP: 4.02 | CX LogD: 4.02 |
Aromatic Rings: 4 | Heavy Atoms: 47 | QED Weighted: 0.17 | Np Likeness Score: -0.08 |
1. Yang,CJ.; Li,B.; Zhang,ZJ.; Gao,JM.; Wang,MJ.; Zhao,XB.; Song,ZL.; Liu,YQ.; Li,H.; Chen,Y.; Lee,KH.; Morris-Natschke,SL.; Xu,C.. (2020) Design, synthesis and antineoplastic activity of novel 20(S)-acylthiourea derivatives of camptothecin., 187 [PMID:31881457] [10.1016/j.ejmech.2019.111971] |
Source(1):